| DVAX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DVAX shares outstanding history going back to 11/10/2014:
Also see: DVAX Market Cap History DVAX YTD Return |
DVAX Shares Outstanding History — Dynavax Technologies Share Count Over Time
As of 11/3/2025 Dynavax Technologies has 117.42 million DVAX shares outstanding. Investors often track the DVAX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows DVAX share count trends over time, with 43 historical shares outstanding datapoints presented, dating back to 11/10/2014.
| DVAX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DVAX Historical Shares Outstanding: +14.59% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DVAX Stock Price Chart |
| About Dynavax Technologies Corp |
| Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company, which is engaged in developing and commercializing vaccines. Co.'s products include HEPLISAV-B hepatitis B vaccine and CpG 1018. Its HEPLISAV-B ((Recombinant)(Adjuvanted) is indicated for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. It also manufactures and sells CpG 1018 adjuvant, the adjuvant used in HEPLISAV-B. It is also engaged in developing a multi-program clinical pipeline leveraging CpG 1018 adjuvant to develop improved vaccines for indications with unmet medical needs. We show 43 historical shares outstanding datapoints in our coverage of DVAX's shares outstanding history. Understanding the changing numbers of DVAX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DVAX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DVAX by allowing them to research DVAX shares outstanding history as well as any other stock in our coverage universe. |
| DVAX Current Stock Quote |
Quotes delayed 20 minutes  Free DVAX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| DVAX Share Performance |
| Shares Outstanding Peers |
| Dynavax Technologies (DVAX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DVCR Shares Outstanding History DWTX Shares Outstanding History DXCM Shares Outstanding History DYAI Shares Outstanding History DYN Shares Outstanding History DYNT Shares Outstanding History EAR Shares Outstanding History EBS Shares Outstanding History ECOR Shares Outstanding History ECYT Shares Outstanding History More Healthcare companies » |
DVAX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
